See the DrugPatentWatch profile for Lofexidine
What is lofexidine, and what is it used for?
Lofexidine is a medication used to help manage symptoms of opioid withdrawal. It works by affecting the nervous system pathways that drive withdrawal-related symptoms. It is used as part of opioid withdrawal treatment plans, typically when transitioning off opioids and trying to reduce withdrawal discomfort. [1]
How does lofexidine work for opioid withdrawal?
Opioid withdrawal symptoms are largely driven by changes in autonomic signaling (the body’s “fight-or-flight” functions) during opioid cessation. Lofexidine reduces those withdrawal symptoms by lowering sympathetic output through action on central alpha-2 adrenergic receptors. [1]
What withdrawal symptoms can lofexidine help with?
Lofexidine is intended to reduce common withdrawal discomforts such as autonomic symptoms (for example, sweating and agitation) and other related physical withdrawal effects, making withdrawal more tolerable during the detox period. [1]
How is lofexidine taken, and how long is treatment?
The exact dosing schedule and duration depend on the clinical protocol used for opioid withdrawal and the product labeling in the relevant country. In practice, lofexidine is taken over a short detox window while withdrawal peaks and then symptoms settle. [1]
What are the main side effects or risks?
Because lofexidine lowers sympathetic signaling, its most important safety concerns relate to blood pressure and heart rate. Commonly monitored risks include low blood pressure (hypotension) and dizziness. Clinicians also watch for other effects consistent with its mechanism of action. [1]
Does lofexidine treat opioid dependence, or only withdrawal symptoms?
Lofexidine is used to manage opioid withdrawal symptoms during detox. It is not the same as long-term maintenance therapy for opioid use disorder (such as methadone, buprenorphine, or naltrexone), which target ongoing relapse risk. [1]
How does lofexidine compare with clonidine for withdrawal?
Lofexidine and clonidine both act on alpha-2 adrenergic pathways and can reduce opioid withdrawal symptoms. In clinical use, lofexidine is often discussed as a more targeted option for withdrawal management, with specific dosing and monitoring considerations tied to the individual product and setting. [1]
Is lofexidine approved everywhere?
Approval status varies by country. Where it is used, clinicians follow local regulatory labeling and guidance for dosing, monitoring, and patient selection. [1]
Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/ (FDA drug information resources)